The principal function of mitochondria is to synthesize ATP through oxidative phosphorylation. Mitochondria are also important for maintaining the tight control of intracellular calcium levels, which is essential for higher organisms. Given these central functions it is not surprising that even small alterations of mitochondrial physiology can lead to disease; the outcome of which can be very different. Over the last decades, it has dawned that in addition to its ATP producing and calcium regulating functions, mitochondria play an important role in intracellular signalling cascades leading to death or survival of the cell in conditions such as hepatotoxicity, ischemia reperfusion damage of brain and heart, cancer and HIV infections [1, 2] . Several mechanisms of mitochondrial involvement in cell death have been proposed, for example increased oxidative stress, altered calcium homeostasis, impairment of respiratory chain complexes, and-more recently-the activation of the mitochondrial permeability transition pore (mPTP); a pore in the mitochondrial membrane bilayer formed by a multi-protein complex. The complex consists largely of voltage dependent anion channel (VDAC), situated in the outer mitochondrial membrane, adenine nucleotide translocator (ANT), situated in the inner mitochondrial membrane, and cyclophilin D, a soluble molecule found in the matrix [3] .
Opening of the pore disrupts the proton gradient, and thus uncouples oxidative phosphorylation. Activation of the mPTP renders the inner membrane permeable to substances ≤1500 Da [4] , leading to osmotic swelling due to the large amount of proteins present in the mitochondrial matrix, and eventually to disruption of the outer membrane with concomitant release of a number of factors from the mitochondrial intermembrane space and matrix into the cytoplasm [5] . The principal activator of the mPTP is calcium; the concentration required depends on the surrounding conditions. Mitochondrial permeability transition (mPT) can be induced by increased calcium concentration in vivo [6, 7] as well as in vitro [8] [9] [10] [11] and may be reversed by removing calcium [9] or prevented by the administration of inhibitors of mPTP, such as cyclosporin A or its non-immunosuppressive analogues [12] . In the experimental setting, membrane permeabilisation can be achieved by drugs such as the mPTP inducer atractyloside or the ionophore alamethicin. The physiological role of the mPT, if any, is not known, but it has been suggested to have a role in calcium homeostasis (reviewed by [11] ). Pathophysiological activation of mPTP has recently been convincingly demonstrated to be critical in ischemia/reperfusion injury and essential to calcium-or oxidative stress-induced cell death. However the mPTP seemed to be of lesser importance to apoptotic cell death during normal development and to apoptosis regulated by proteins of the Bcl-2 family [13, 14] . As shown by Morin et al, cytochrome c release from liver mitochondria occurs independently of mPTP during ischemia, whereas it occurs dependent on mPT in the reperfusion interval [7] . mPT thus has different importance in different settings. Mitochondrial protein release can also be stimulated by proapoptotic members of the Bcl-2 family of proteins (e.g. Bax, tBid); these proteins are generally regarded to mainly induce selective outer membrane permeabilisation independent of mPT [15] . Unlike the anti-apoptotic Bcl-2 proteins, which appear to be exclusively membrane bound, their proapoptotic counterparts (e.g. Bax, Bad, Bim, Bmf) are mainly localized in the cytosol or associated with cytoskeletal proteins under nonapoptotic conditions [16] . Following a death signal, these proteins translocate to mitochondria, where they regulate the activity of the Bcl-2 proteins. Under normal conditions, Bax predominantly exists as a monomeric protein and has cytosolic distribution, but following activation during cell death, Bax translocates to the mitochondria [17] , and induces homodimerization [18] [19] [20] . Bax then integrates in the outer mitochondrial membrane, and causes release of proteins from the intermembrane space, e.g. cytochrome c [21, 22] , which triggers apoptosis. In addition to Bax, the BH3-only proapoptotic proteins, e.g. Bid, translocate from the cytosol to the mitochondria following activation. Bid is activated by cleavage of its amino terminus by caspase-8 during TNF -or Fas-induced cell death to form the truncated version tBid, which can interact with Bax or Bak to facilitate its oligomerization [23] [24] [25] . Currently, only a limited number of the proteins released from mitochondria upon e.g. calcium-induced mPT or following stimulation with proapoptotic Bcl-2 proteins are known. Examples of released factors are apoptosis inducing factor (AIF), cytochrome c, SMAC/DIABLO, and hsp10 [5] . These factors may participate in the activation of cell death programs in several different cell types. It is currently not known if induction of mitochondrial protein release by calcium or proapoptotic Bax results in the release of the same or similar proteins, i.e. if the pathway of cell death is identical downstream of mitochondrial protein release. It could be speculated that the inducer of mPT determines which proteins are released, but so far no conclusive studies have been performed on this subject. Attempts at identifying proteins released following mPTP or selective outer membrane permeabilisation induced by truncated Bid (tBid) in vitro, have been performed during the last years [26] [27] [28] . However, several of these studies encountered the obstacle that non-specific leakage of proteins from mitochondria, probably caused e.g. by mitochondrial rupture following repeated centrifugations and resuspensions, is very high in vitro.
The high non-specific background contaminates the proteins that were specifically released, making identification of specifically released proteins very difficult. To identify the proteins that are released, it is helpful to apply open-approaches, i.e. to include all proteins independent of their physical characteristics (e.g. size, isoelectric point (pI)). The recent advances within the proteomics field have provided the necessary tools, and reports of open-approaches looking for proteins released from mitochondria have been published [26] [27] [28] [29] . To identify individual proteins in a complex mixture, several proteomics-based approaches have become available lately. In general, these strategies are composed of a separation and an identification step. The traditional way to separate complex protein mixtures is by 2D gel electrophoresis, but this method is problematic for mitochondrial proteins, since they often have extreme pI [30, 31] . Alternative methods of separation are by 1D polyacrylamide (PA) gel electrophoresis or by liquid chromatography (LC). As these techniques do not rely on pI, they are preferable for separation of mitochondrial proteins. Identification of proteins from tryptic peptide fragments can be performed using mass spectrometry (MS), as in peptide mass fingerprinting, or tandem mass spectrometry (MS/MS) where selected peptide ions are fragmented, allowing sequence information from that particular peptide to be obtained. The objective of the present study was to establish a method, which would allow collection of specifically released proteins, i.e. reduce the high non-specific background. To achieve this, we used cryogel monoliths (denoted monoliths hereafter), which is a sponge-like material composed of large (10-100 µm) interconnected pores [32] , to bind mitochondria. The poly(acrylamide)-based continuous macroporous structure and non-adhesive properties of the polyacrylamide-based pore walls allow for free passage of bio-nanoparticulates (inclusion bodies, viruses, cells etc.) through plain monoliths in the absence of affinity interactions with the matrix [32, 33] . These properties make monolithic adsorbents highly suitable for the processing of particulate-containing samples. Affinity monoliths have previously been exploited for the fractionation of different types of mammalian [34] and bacterial [35] cells, affinity capture of viruses [36] and for integrated capture/purification of recombinant proteins from non-clarified cell culture fluids [37, 38] . Chelating affinity monoliths with immobilised Cu2+ will bind mitochondria, most likely through histidineresidues on their surface. The objective of the present study was to establish a method, which would allow detection of proteins released specifically from mitochondria following stimulation with agents known to promote mitochondria permeabilisation. To achieve this, mitochondria were attached to monoliths, unspecific proteins were washed away, and mitochondria were subjected to calcium or a combination of Bid and Bax in doses that resulted in large amplitude swelling in mitochondria in suspension [9] . We demonstrate that proteins specifically released from mitochondria can be isolated and identified without the problem of a high background of unspecifically released proteins. This novel method may serve as a valuable tool to analyze pathways of mitochondrial signalling in this and other systems.
Materials and Methods

Materials
Percoll was purchased from Pharmacia; all other chemicals were ultra grade and purchased from SigmaAldrich, and its associated suppliers. Recombinant mouse Bid (75-195) and Bax (38-171), both truncated to increase efficiency [39] were purchased from ProteinX lab (USA).
Cryogel monolith preparation Epoxy-activated monoliths were produced as previously described [37] . In brief, epoxy-activated monoliths (plugs 12.5 x 7.1 mm) were produced using 3.5% solution of co-monomers (Acrylamide, N,N`methylenebis(acrylamide), and allyl glycidyl ether) in the reaction mixture with ammonium persulfate and TEMED as initiators. Coupling IDA ligands to epoxy activated monoliths was carried out according to [37] . The amount of chelate groups was determined to be 13 µmol/ml adsorbent by assaying the amount of bound Cu2+ ions.
Mitochondria preparation Mitochondria were isolated from rat liver tissue using differential centrifugation according to Halestrap and colleagues [40] with slight modifications [10] . Animal procedures were approved by the Malmö/Lund Ethical Committee for Animal Research (M224-03). Adult male Wistar rats, 350 -450 g, were briefly sedated with halothane and euthanized by decapitation. The liver was rapidly removed and put into ice-cold isolation buffer (IB) (320 mM Sucrose, 2 mM EGTA, 10 mM Tris, pH 7.2). Homogenization of liver tissue was performed in IB (10% w/v) containing 0.5% BSA using a 10 ml Kontes Teflon Homogenizer, size 22. The homogenate was centrifuged in a Beckman Avanti Centrifuge with F1010 rotor at 311 x g for 10 min at 4°C. The supernatant was decanted and centrifuged at 7,800 x g for 5 min. The resulting pellet was resuspended in IB with 19% Percoll in order to remove contaminating membranes and centrifuged at 11,220 x g for 10 min. A last washing step of the pellet was performed in IB at 7,800 x g for 5 min and the final pellet was resuspended in a small volume of IB. The concentration of mitochondrial protein was determined by the Bradford method using BSA as standard [41] . Prior to use, the mitochondria were diluted in swelling buffer (250 mM sucrose, 20 mM MOPS, 10 mM Tris, 2 mM K2PO4, 1 mM MgCl2, 1 µM EGTA, pH 7.2) to yield the desired concentration. This protocol results in a mitochondrial preparation essentially free of contaminating organelles, such as endoplasmatic reticulum [9] . All experiments were conducted within 6 hours of decapitation of the rats. A total of 6 rat livers were used for the final protein release experiments using calcium to induce mPTP. A seventh liver was used for identification of Bid/Bax released proteins.
Detection of mitochondrial permeability transition pore activation Activation of mitochondrial permeability transition was monitored as described previously [10] by measuring the decrease in 90° light scattering at 520 nm (mitochondrial swelling) using a Perkin-Elmer Spectrometer LS-50B. The decrease in light scattering closely parallels the percentage of the mitochondrial population undergoing permeability transition [42] .
Calcium-stimulated release of proteins in suspension To induce mPT in suspension, mitochondria (approx. 2 mg) were pre-incubated in swelling buffer containing 5 mM malate and 5 mM glutamate for two minutes, and stimulated with 2 µmol CaCl2 per mg mitochondria for 8 min at 37 °C. After 5 min of incubation, a protease inhibitor cocktail ("General use", Sigma) was added. The protease inhibitors were not added from start, because it has been suggested that release of some proteins following mPT may depend on protease activity [43] . The sample was centrifuged at 7,000 x g for 7 min, followed by centrifugation of the supernatant at 20,000 x g for 15 min, and the resulting supernatant was stored at -80°C until further processing.
Calcium-stimulated release of proteins on cryogel monoliths To bind mitochondria, monoliths (12.5 x 7.1 mm diameter) were inserted into the wells of a 96-well microtiter plate with open-ended wells, conditioned with 6 volumes (1 volume=0.5 mL) of 0.25 M CuSO4, washed with milliQ H2O, and equilibrated with 6 volumes of monolith swelling buffer (CS-buffer) (250 mM sucrose, 20 mM MOPS, 10 mM Tris, 2 mM K2PO4, 1 mM MgCl2, 10 mM imidazole, 5 mM malate, 5 mM glutamate, pH 7.2) at room temperature. Imidazole was included in the swelling buffer to reduce binding of both mitochondria and released proteins to the monolith surface, as initial studies had shown that the binding of mitochondria to monoliths was very strong. 1.5 mg mitochondria were suspended in 250 µl CS buffer and loaded on a monolith. Following 6 min of incubation, the monoliths were washed with 10 volumes of CS buffer. After quantifying the amount of mitochondria in the eluate by Bradford as well as light scattering at 520 nm, the eluate was discarded. To induce mPT in the mitochondria, 300 µl CS buffer, containing 8 µmol CaCl2 per mg mitochondria, was loaded on the monoliths, and incubated for 8 min. This dose resulted in swelling of a majority of mitochondria bound to monoliths as verified by electron microscopy (see below). The released proteins were eluted into a 96 well plate containing protease inhibitor cocktail ("General use", SigmaAldrich) using 2 volumes of CS buffer. The eluates were centrifuged (7,000 x g, 7 min, followed by 20,000 x g, 15 min), and the resulting supernatant was stored at -80°C until further processing. See figure 1 for illustration of approach.
Bid and Bax stimulated release of proteins on cryogel monoliths
Protein release by Bid and Bax was performed essentially as for calcium-stimulated release. 1 mg mitochondria were loaded on each monolith and CS buffer containing 5 µg/mL of each of Bid and Bax were added following washing with 10 volumes of CS buffer. Incubation proceeded for 60 min to induce permeabilization of the mitochondria.
Electron microscopy Mitochondria were bound to monoliths, and subjected to i) control conditions (CaCl2 free CS-buffer), ii) 8 µmol CaCl2 /mg of mitochondrial protein in CSbuffer, or iii) alamethicin (0.167 µg/µl) in CS-buffer as described above. Bid/Bax treated mitochondria were not examined by electron microscopy. Following elution of released proteins, the mitochondria were fixed by passing 1 volume of fixing solution (1.5% paraformaldehyde, 1.5% glutaraldehyde in Sørensen buffer (0.1 M phosphate buffer)). The monoliths were gently removed from the 96 well plate and left in fixing solution for 1 h at room temp, and overnight (o.n.) at 4 °C followed by washing to remove the fixing solution (twice; Sørensen buffer). Further fixing was performed in 1% OsO4 in cacodylate buffer (1 h, room temp.), followed by dehydration in increasing concentrations of ethanol (25%, 50%, 75% and Abs). For scanning electron microscopy (SEM) critical point drying, and sputter coating in gold/palladium was performed. SEM was performed on a JEOL JSM-5600LV scanning electron microscope. For transmission electron microscopy (TEM), samples were dehydrated in ethanol followed by acetone, and embedded in epon resin. Ultrathin sections (50 nm) were cut using a diamond blade, and stained with 2% uranyl acetate and lead citrate in a LKB ultrastainer. A JEOL JEM-1230 transmission electron microscope, coupled to a Gatan CCD-camera, was used for TEM.
ATP assay
Mitochondrial viability is commonly evaluated by determining phosphorylative coupling of respiratory activity, i.e. the ability to convert ADP to ATP in the . Schematic illustration of approach. Mitochondria suspended in CS-buffer were loaded on cryogel monoliths, spontaneously released proteins were washed away, and the mitochondria were exposed to CS-buffer, or CS-buffer containing CaCl2 for 8 min or to Bid/Bax-containing CS buffer for 60 min. (1) . The released proteins were eluted from the monoliths by passing CS-buffer. The eluates were concentrated and buffer exchanged (2) using spin concentrators (Ultra4, millipore). 40 µg protein from calcium samples were separated on a PA gel alongside control samples (3), and the PA gel was cut in pieces of approx. 7 mm (4). The gel pieces were subjected to in situ trypsin digestion and the generated peptides were extracted from the gels and analysed by LC-MS/MS (5).
presence of substrate and oxygen. In mitochondria bound to monoliths, this ability was evaluated by measuring the amount of produced ATP in the eluates. Mitochondria were bound to monoliths in CS-buffer, unbound mitochondria were washed away, and mitochondria were subjected to incubation in CaCl2-free CS-buffer (control) or to CaCl2 containing CSbuffer for 8 min. Subsequently the mitochondria were incubated with 2 mmol ADP in CS-buffer for 8 min. This buffer was displaced by two volumes of CS-buffer, the eluate was collected and assayed for ATP content using an ATP determination kit (Molecular Probes) based on emission of bioluminescence from the luciferase-driven conversion of luciferin to oxyluciferin under ATP consumption. Bioluminescence was detected in a Packard Tri-Carb 2100TR liquid scintillation analyzer as described by the kit manufacturer. ATP production from mitochondria in suspension was assayed in a similar way. Following 8 min exposure to CaCl2-free (control) or CaCl2 containing CS-buffer, 2 mmol ADP was added to the buffer and the mitochondria were allowed to produce ATP for 8 min.
Following removal of the mitochondria by centrifugation, the ATP content of the remaining supernatant was assayed.
Processing of proteins Calcium released proteins from a total of 3 mg mitochondria (i.e. eluate from 2 monoliths) were pooled and concentrated on Millipore ultra4 spin concentrators, and buffer exchanged to TE-buffer (10 mM Tris, 5 mM EDTA, pH 7.0). Eluates from Bid/Bax stimulated mitochondria (2 mg total) were processed in a similar manner. Protein content was measured using the Lowry protein assay (DC protein assay, BioRad) using BSA as a standard. Depending on the protein concentration, 2-3 calcium treated samples were pooled resulting in 40 µg protein per final sample. Equivalent volumes of control samples were pooled, and the protein content was found to be below the detection limit ( 7 ng/ul) for both 8 min and the 60 min concentrated control samples. For 8 min control and calcium treatment, the three replicates were produced from mitochondria purified from 6 individual rat livers. For Bid/Bax only one sample, originating from one liver, was processed for protein identification. Following standard procedures, the samples were loaded on a polyacrylamide gel (henceforward abbreviated "PA gel") (stacking gel 4% polyacrylamide, separation gel 10-20% gradient polyacrylamide, BioRad), and run alongside an equivalent incubation sample as well as a Kaleidoscope Prestained Standard size marker (BioRad) until the bromphenolblue reached the bottom of the gel. The gels were stained in Coomassie G-250 for 2 hours and destained o.n. Pilot experiments showed that the protein levels in the control samples could not be detected or identified in the subsequent analyses, and these samples were therefore not processed further. The PA gel lanes were cut in pieces of approx. 6 mm, resulting in 10 gel pieces per sample (see figure 1) . Coomassie stain was removed from the gelpieces by washing (40% acetonitrile, 25mM NH4CO3), and the proteins were reduced (10 mM DTT in 25 mM NH4HCO3, pH 7.8) and alkylated (25 mM iodoacetamide in 25 mM NH4HCO3). Reducing and alkylating agents were removed prior to o.n. digestion by trypsin (0.10 µg trypsin in 25 mM NH4HCO3). The digestion was terminated by adding 1% TFA, and peptides were extracted twice using 50% Acetonitrile / 0.1% TFA, desalted on stagetips [44] , dried, and dissolved in 10 µl 0.1% formic acid. Samples were placed in glass QsertVials (Waters), and stored at 4°C.
LC-MS/MS
The digested proteins were separated on an UltiMate (LC-Packings) liquid chromatography system and identified using an Esquire HCT (Bruker Daltonics) ion-trap mass spectrometer. 4 µl of the extracted peptides were analysed in each run. The reverse phase chromatography was run on a capillary column (Atlantis dC18, 150 µm x 150 mm, 3 µm, Waters) with a binary mobile phase gradient of 5-54.5% B in 33 min (A: water:acetonitrile 97:3, 0.1% formic acid, B: water:acetonitrile 20:80, 0.1% formic acid). The flow rate was 2 µl/min and the column outlet was directly connected to the microflow nebulizer of the electrospray interface operating at a capillary voltage of 4000V. Using the same digested samples, the LC-MS/MS experiments were run twice with slight changes in the experimental conditions. The MS was always run in enhanced mode (scan speed 8,100 (m/z)/s) while the MS/MS was run either in enhanced or in ultrascan (26,000 (m/z)/s) mode. The maximum number of ions in the trap was changed (ion charge control) from 200,000 (1st run) to 100,000 (2nd run), and the threshold was furthermore increased from 40,000 (1st run) to 100,000 (2nd run). The ion selection was set to exclude singly charged ions and to pick 2 precursors from each MS scan to perform MS/MS. Precursor ions were excluded from MS/MS sampling when 3 (1st run) or 2 (2nd run) MS/MS runs had been performed. The preferred target mass was set to 800 m/z (1st run) or 700 m/z (2nd run). For the LC, the same gradient was applied in both runs, but the run time was reduced from approx. 60 min to 45 min in the second run. Each region of the PA gel was thus analyzed twice in three replicates by LC-MS/MS.
Data analyses
The data was processed with Biotools software (Bruker Daltonics) and the resulting mascot generic files (mgf) were submitted for searches using web- Scanning electron microscopy of monoliths showed that they had a continuous macroporous structure with a spongy morphology. Mitochondria had a round structure, and were bound to the monoliths in a nonorientable way, often in clusters in a "grape-like" structure. Upon visual inspection, no difference in the amount of bound mitochondria, or the grape-like structures, was seen between the three types (control, calcium, alamethicin) of treatments. Examination of an internal part of a monolith showed that slightly less mitochondria were bound half way down the monolith; all other characteristics remained the same indicating that the binding was uniform and that the binding capacity of the monoliths was not exceeded. Both SEM Figure 2 . Electron microscopy. Scanning and transmission electron microscopy (SEM and TEM) of cryogel monoliths at increasing magnification: First row: untreated mitochondria, Second row: calcium-treated mitochondria, Third row: alamethicin treated mitochondria. At low magnification (55 X, first column) the porous structure of the cryogel monoliths is seen using SEM. Increasing the magnification (1100 X, second column) show that mitochondria bind to the surface in clusters. At high magnification (4500 X, third column) SEM show that the diameter of calcium and alamethicin treated mitochondria is increased compared to untreated mitochondria. TEM (12.000 X, fourth column) shows that the matrix of the treated mitochondria (calcium and alamethicin) is less dense than control mitocondria, i.e. mitochondria are swollen. These results are in line with a decreased ATP producing ability of the treated mitochondria. Scale bars indicate 100 µm, 10 µm, 1 µm, and 0.5 µm for columns 1-4, respectively and TEM found the diameter of untreated mitochondria to be slightly less than 1 µm, approx. 1 µm for calcium treated, and slightly above 1 µm for alamethicin treated mitochondria (see figure 2) , as visualised by electron micrographs at 4500 x and 12.000 x magnification, respectively. Applying a very high dose of alamethicin resulted in complete disruption of the mitochondria; SEM showed mitochondria with large holes as well as small, resealed particles (data not shown).
Transmission electron microscopy displayed a dense matrix of the untreated (control) mitochondria, and increasing swelling of the matrix in calcium or alamethicin treated mitochondria. figure 3 , suspension). The unspecific protein release did not decrease when the experiments were performed at room temperature (i.e. lower temperature). Different protocols for isolation of mitochondria were tested in an attempt to reduce the unspecific protein release, but it was never possible to reduce it to below 30% of that of calcium-induced samples (data not shown). The ATP production of mitochondria bound to monoliths was found to be somewhat higher than that of mitochondria in suspension (27 nmol/mg/min vs. 17 nmol/mg/min respectively). Upon stimulation with calcium, the ATP production decreased to 38% on monoliths and to 21% in suspension, respectively. Figure 3 . Polyacrylamide gels. Mitochondria in suspension or bound on monoliths were stimulated with 2 and 8 µmol CaCl2/mg mitochondria respectively, or 5.0 µg/mL Bid and Bax, and released proteins were collected and separated on polyacrylamide gels. The first two lanes contain proteins released from mitochondria in suspension (incubation and calcium); Lanes 3-6 contain proteins released from mitochondria bound to monoliths. Lane 3 and 5 contain incubation samples (-), whereas lane 4 and 6 contain proteins released by calcium or Bid/Bax (+). Proteins released in suspension were separated on a 20 cm long 4-20% PA gel, whereas proteins released from bound mitochondria were separated on a 7 cm long 10-20% PA gel. Horizontal arrows indicate size in kDa. In suspension, the staining of the nonspecifically released proteins is almost as intense as that of proteins released upon calcium stimulation. When protein release is induced in mitochondria bound to monoliths, the nonspecifically released proteins can be washed away prior to analysis, and do thus not disturb the identification of the specifically released proteins (essentially no staining on PA gel). The proteins identified are thus specifically released upon mPT induction. In situ trypsin digestion, extraction and LC-MS/MS analysis on such samples (-/+ calcium in suspension) found no difference in the proteins present in the two situations. different stimuli.
LC-MS/MS
Pilot experiments showed that PA gel separation of 40 µg of proteins, released by calcium stimulation, resulted in identification of approx. 70 proteins. However, the control samples from suspension experiments contained a similar protein profile, albeit at lower concentration, meaning that it was not possible to identify proteins released as a result of the experimental manipulation. In the control samples from mitochondria bound to monoliths, it was not possible to detect, nor identify any released proteins (data not shown). These samples were therefore not included in the final LC-MS/MS analysis. For the two LC-MS/MS runs performed, complementary data were obtained. Based on results from the first run, the settings for the second run were optimized as described in materials and methods section. The adjustments resulted in better MS/MS data as well as better mass accuracy and resolution. Similarly, the increased threshold improved the quality of the data. The changed target mass resulted in a somewhat different set of selected peptides for MS/MS, thus complementing the first analysis. The quality of the MS/MS spectra was best in the second run, often allowing 5-7 consecutive ions to be assigned to peaks in the spectra with root mean square errors below 100 ppm. The total ion composition trace showed that, as expected, the amount of sample present in the different gel pieces varied. Approx. 600 MS/MS spectra from each gelpiece were included in the database searches of both the web-accessible and the in-house Mascot search engines. In spite of the web-based Mascot search engine only allowing 300 spectra per search, we only found differences in the ions scores assigned (measure of the quality of the data), but no difference in the identified proteins when the result were compared to those obtained using the in-house version of Mascot. We did not attempt to calculate percent sequence coverage for searches performed with the in-house Mascot, but it might be higher than what we have displayed here (supplemental data, Table 1 ). Searching Swiss-Prot and National Center for Biotechnology Information (NCBI) databases also identified essentially the same proteins, when naming redundancies were eliminated. The results displayed in Table 1 are generated from searching the Swiss-Prot database using the web-based mascot search engine. As we found no differences between searches performed in NCBI and Swiss-Prot, we have displayed Swiss-Prot entry names and protein names, to avoid redundancies. From each gel slice, between 1 and 18 proteins were identified. A total of 68 unique proteins were identified in the calciumstimulated samples using the above stated criteria; 44 were identified in both LC-MS/MS runs, 9 were identified only in the first run, and the remaining 13 in the second run. These numbers include identifications made in only one sample. 41 of the proteins were identified in all three replicates from the different mitochondrial preparations. 81% of the proteins were identified by more than one peptide (see supplementary data, Figure 1 , for a distribution of number of peptides per protein). For Bid/Bax released proteins, 82 proteins were identified in the single analysis performed; 45 of these were identical to proteins released by calcium. We did not attempt to look for specific proteins in the unassigned spectra. For a more extensive list of released proteins including their sizes, numbers of identified peptides and sequence coverage, see supplemental data, Table1. Obvious contaminants, such as keratin and trypsin, were not included in these lists. The contaminants yielded low ions scores, and most were only identified by a single peptide. According to ExPaCy's "subcellular localization" classification, 63% of the calcium released proteins are localised to mitochondria, 12% in the cytosol, 6% are peroxisomal proteins, 3% are nuclear protein, and 4.5% are either secreted or ER proteins. For 12% of the proteins SwissProt does not provide information on the location of the protein. A similar distribution was seen for Bid/Bax released proteins.
Discussion
A few decades ago mitochondria were considered to be a power plant having only one purpose, namely to produce ATP for the cell. This is now known not to be the case; in addition to production of ATP, mitochondria actively participate in the intracellular signalling by releasing specific proteins upon a given stimulation, some of which participate in induction of cell death programs that are important for the propagation of cell death in e.g. neurodegenerative disease, myocardial infarction and liver ischemia. The mitochondrial permeability transition pore allows such release, as does stimulation with proapoptotic members of the Bcl-2 family of proteins, e.g. tBid and Bax. Calcium is a central mediator of intracellular signals, and is involved both in physiological and pathophysiological cell signalling. Intracellular calcium levels may increase as a result of injury, e.g. excitotoxic injury caused by excessive release of glutamate in the brain. As calcium enters the cell, it is sequestered in mitochondria as a consequence of the mitochondrial membrane potential, and may there induce mPT. The dynamics of calciuminduced stimulation of mPT is complex, and it has been suggested that in vivo, mitochondria may release proteins as intracellular calcium levels increase e.g. as a result of injury [6, 7] . As the tissue recovers, calcium may be extruded from the cell, and the mPTP reverts to the closed state. Released proteins (e.g. cytochrome c) may then be taken up again by the mitochondria, and the initiation of cell death programs cancelled. Pharmacological inhibition of the mPT and the associated release of cell death-inducing proteins have been shown to have a very potent cytoprotective effect in several settings [45] , and so has counteracting the proapoptotic effects of Bax by e.g. over expression of Bcl-2 [46] . As mentioned in the introduction, it is currently not clear if the mPT and Bax mediated pathways converge in mitochondria and share a common downstream pathway in the induction of cell death. Therefore, the mechanisms underlying activation of mPT and Bax-mediated cell death, as well as the identity of the released factors have been the focus of intense research over the last decade. Several approaches for studying protein release from mitochondria have been published [15, [26] [27] [28] ; all of these studies have brought about interesting information about proteins released from mitochondria. They used centrifugation/resuspension to isolate mitochondria and suspensions to collect the proteins released following stimulation, and although data from the control samples are not presented in all studies, they all indicate that there was a high degree of unspecific release (background), which in line with our findings. This unspecific release is probably caused by mitochondria bursting as a result of the (unphysiological) forces caused by repeated centrifugation and resuspension. This paper is the first to indicate a solution to the problem of unspecific protein release, and presents a tool that can be used to delineate the effects of different stimuli leading to mitochondria-mediated cell death. We show that by binding mitochondria to monoliths, it is possible to wash nonspecifically released proteins away prior to performing the actual experiments. This allows the isolation of the specifically released proteins, and hence a Table 1 Released proteins. Specifically released proteins from calcium stimulated liver mitochondria. Swiss-Prot entry name and protein name is listed for the 68 proteins identified in the two LC-MS/MS analysis'. Proteins identified from peptides with 95% confidence in one sample are included in the list. 81% of the proteins were identified by two or more peptides. Obvious contaminants (e.g. keratin and trypsin) were not included. For a more detailed list, including identification in the three replicates, see supplementary data. more detailed insight into which proteins are released as a result of the experimental manipulation, rather than by centrifugation and resuspension of the mitochondria. Monoliths have previously been used to separate, isolate or fractionate cells, viruses and recombinant proteins. By changing the binding surface of the monoliths it is possible to apply them in almost any situation where separation is needed. Water or buffer inside the pores of the monoliths constitutes nearly 90% of their weight [32, 47] . The environment is thus very similar to the commonly used in vitro system for studying mitochondria, i.e. suspension. Due to capillary forces, the liquid is kept inside the pores and can be displaced from the monolith by addition of a new portion of liquid. This makes the monoliths ideal for binding and studying mitochondria. Scanning-and transmission electron microscopy showed that upon calcium stimulation, mitochondria display the same morphology as previously reported for mitochondria in suspension following calcium stimulation [9] . When bound to monoliths, mitochondria cluster together in "grape-like" structures independent of their treatment. Clustering has also been reported from atomic force surface scans of mitochondria in vitro [48] and might thus be an intrinsic feature of mitochondria in vitro. The ATP production was found to be intact in control samples of mitochondria bound to the monoliths, indicating that the mitochondria were viable after binding to the monoliths. The ATP production was disrupted following addition of calcium, both in suspension and in samples bound to the monoliths, suggesting a similar functional response to a calcium challenge. Furthermore, the diameter of monolith-attached mitochondria was similar to that of mitochondria in suspension, both in control samples and following a calcium challenge. The characteristics of mitochondria bound to monoliths are thus apparently identical to those of mitochondria in suspension. The binding of the mitochondria to the monoliths is quite robust; once the mitochondria are bound, they are not released by several passages of buffer, or by addition of permeabilising agents. Incubation of up to 60 min does not induce spontaneous rupture or unspecific protein release yielding a blank incubation sample. The calcium dose necessary to elicit swelling of a large portion of mitochondria bound to monoliths is four times higher than the dose needed for a similar degree of mitochondrial swelling in suspension. This could be caused by restricted diffusion within the monoliths; as mitochondria are immobilised, the probability of encountering a calcium-ion are lower than if they were moving freely. A similar phenomenon is seen for agonist-binding studies on monoliths (M. Dainiak, unpublished studies). The ATP production was found to be intact for the applied Bid and Bax dose, which is consistent with the suggested role of Bid/Bax in permeabilization of only the outer mitochondrial membrane.
Taking the above-mentioned concentration-effects into consideration, further studies on the microscopic morphology of the mitochondria treated with Bid/Bax should be performed to firmly establish the consequences of the applied dose in the monolith system. For the identification of the released proteins, a proteomics method, which combines PA gel electrophoresis, liquid chromatography and tandem mass spectrometry, was applied. The method is simple and easily performed by researchers with limited experience on PA gels and LC-MS/MS [31] . The method allows detection of individual proteins in a complex solution of proteins, with a sensitivity of 10 fmol, and circumvents the problem of resolving mitochondrial proteins, which often have extreme pI [30, 31] , on 2D gels. The technique is performed most elegantly on a HPLC coupled directly to a mass spectrometer, but can also be performed off-line. By separating the proteins according to size, using PA gel electrophoresis, prior to LC-MS/MS analysis, only peptides from a limited number of proteins will be present in each sample. This allows the threshold for the analysis to be set low, and for the MS/MS runs to take up more time as fewer peptides elute simultaneously. Hereby efficient identification of many peptides is allowed, which results in good sequence coverage of the identified proteins, and in identification of low abundant proteins. For the current set-up 81% of the identified proteins were identified by two or more peptides (See supplemental figure 1 ). Should the sample contain too many proteins, the lower abundant proteins will be disguised by the high abundant proteins, and thus not included in the MS/MS analysis. By simply dividing the PA gel in smaller slices, it is possible to reduce the complexity of the protein mixture, thereby increasing sensitivity to low abundant proteins. Methods such as affinity-purifying peptides containing cysteinyl residues [29] prior to analysis by LC-MS/MS can also be used to simplify protein mixtures, but include more laborious steps and probably increased loss of low-abundance peptides compared to the technique applied in this study. The applied LC-MS/MS method does not allow quantitative comparisons to be performed, but as the unspecific release (background) has been eliminated, this is not required. We found that the band profile of both calcium and Bid/Bax released proteins were reproducible and similar to each other. A comparison of the proteins identified by LC-MS/MS showed that a majority of the proteins were found in both the calcium samples and the Bid/Bax sample. The same degree of inter-sample variation, found for the three calcium samples, was seen between the calcium and the Bid/Bax sample. For the proteins unique to either permeabilising agent, there was no difference in the studied characteristics, such as size and localisation, indicating that the end effect of calcium and Bid/Bax stimulation is release of highly similar proteins. Our results indicate nothing on the similarities in the mechanism of release, but indicate that with the applied concentrations of Bid/Bax, the end result is release of proteins from both the intermembrane space, and the matrix for both calcium and Bid/Bax. A study somewhat similar to ours was performed by Patterson et al [26] using atractyloside to open the mPTP, and LC-LC/MS-MS to detect released proteins. Atractyloside is a ligand for the ANT component of the pore, increasing the open-probability of the pore [3] by stabilising the "c conformation" of ANT thereby increasing its sensitivity to calcium, and resulting in opening of mPTP. As atractyloside binds non-reversibly to ANT, the pore opening cannot be reversed as opposed to calcium induced mPTP. Patterson et al [26] identified 34 of the 68 proteins we identified, as well as 57 proteins not seen in our analysis. We on the other hand detected 34 proteins, which were not detected upon atractyloside treatment. When comparing the characteristics of the proteins released by atractyloside treatment [26] , we find that the two techniques display proteins of essentially the same size, and that there is no apparent difference in the nature or function of the identified proteins. The cellular localization of the identified proteins is also similar in the two studies. The fact that our results from samples, where the background has been eliminated, so closely resembles those of Patterson et al suggests that the release mechanism following mPT-induction using calcium and atractyloside are similar, and that the release of proteins occur in an unspecific way, likely due to osmotic swelling and rupture of the outer mitochondrial membrane. Importantly, this conclusion was not possible until the non-specific release was eliminated. Van Loo [27] used tBID to stimulate protein release from mitochondria. They applied technique similar to ours for detection (PA gel electrophoresis followed by LC and MALDI analysis for relevant bands), but as the unspecific release was almost similar to the tBIDstimulated release, they were only able to detect 7 of the 68 and 83 proteins we detected in our analyses. They identified a further 9 proteins, several of which are low abundant, thus explaining our lack of identification using the less sensitive MS/MS technique. The presented list of proteins includes some of the proteins known to be released from mitochondria, such as Cytochrome c and Hsp10. It however lacks some candidates previously described to be released during mitochondria mediated cell death. Proteins such as Smac/DIABLO, EndoG, Omi/HtrA2 and AIF have all been described to be released from mitochondria following induction of mPT or by Bax-stimulation. Although some of these proteins require specific conditions, e.g. concomitant activation of Calpains to be released [49] and thus may not be released in our model, the most likely explanation for their absence is their low abundance, as was also indicated by Patterson et al [26] . For example, AIF constitute less than 0.1 % of mitochondrial proteins [50] , and is thus close to the detection limit of this technique. To enhance detection of low abundance proteins, the LC-MS/MS analysis can be re-run with preference to peptides not identified in the regular run, with preference to peptides from proteins of interest, or the PA gel can be further divided in smaller sections to reduce the number of proteins in each sample. Other techniques for protein identification with greater sensitivity, such as MALDI-TOF-TOF, could also be applied. This was not attempted in the current analysis. For a number of reasons, it is difficult to study mitochondrial function in situ, and mitochondrial experiments in vitro is at present the experimental system that best allows experimental manipulation and evaluation of mitochondrial response. However, the in vitro system means that mitochondria are removed from the intracellular environment, and subjected to repeated centrifugations etc. Using the method presented here, mitochondria could be subjected to experimental manipulations closer to those in situ, without being subjected to repeated centrifugations. One example would be a transient calcium challenge, where administered calcium is washed away after a suitable time, and the mPTP allowed to revert to the closed state [9] . Further, the monoliths could be coated with intracellular proteins of interest, e.g. cytoskeleton proteins to allow for mitochondrial interaction with other cellular constituents in the experimental setting. The present paper thus presents a new method for studying protein release from isolated mitochondria. The method circumvents the obstacle of protein leakage from mitochondria, and looks at proteins specifically released from mitochondria as a result of cell deathinducing signals. We demonstrate that mitochondria bound to monoliths retain their usual characteristics, such as ATP generation and swelling. By combining separation of proteins based on size with LC-MS/MS, we identified 68 proteins specifically released upon calcium stimulation of liver mitochondria. We furthermore show that the profile of proteins released by calcium and Bid/Bax are similar, indicating that the end results of these two treatment types are identical. To comprehend the complex biology of protein release from mitochondria detailed studies need to be performed; we have now introduced a tool, which will allow these studies to be performed, and encourage the scientific community to take up this challenge. More than half of the proteins were identified by three or more peptides. Proteins, only identified by one peptide are included in the list of released proteins if the ions score indicate that the match is not random (-10Log(P), where P is the probability that the observed match is a random event). As the obtained MS/MS data yields high ions scores, and the spectra are of good quality, we find this acceptable, although the risk of false assignments is higher for this group of proteins. 
